An open label randomised controlled study to compare role of amitriptyline versus propranolol in treatment of migraine with calcified neurocysticercosis
Not Applicable
Recruiting
- Conditions
- Health Condition 1: G439- Migraine, unspecified
- Registration Number
- CTRI/2023/05/052791
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients presented with migraine according to ICHD 3 criteria
2) NCCT HEAD showing calcified granuloma
Exclusion Criteria
1) Patients who are a k/c/o asthma and ecg s/o AV block or bradycardia.
2)Patients with seizures.
3)Patients refusing consent.
4)Patients already on preventive medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will compare change in headache frequency between the two groups at the end of 1st, 2nd and 3rd months. <br/ ><br>Timepoint: 1st, 2nd and 3rd months. <br/ ><br>
- Secondary Outcome Measures
Name Time Method We will also compare severity of headache [VAS ] and disability caused by headache [ HIT6] between the two groups at the end of 1st, 2nd and 3rd months. <br/ ><br>Timepoint: 1st, 2nd and 3rd months